GenMark Diagnostics Schedules Third Quarter 2017 Financial Results Conference Call for November 2, 2017
GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its third quarter earnings results after market
close on Thursday, November 2, 2017. Management will hold a conference call to review the Company's financial performance starting
at 4:30 p.m. ET on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the
GenMark Diagnostics, Inc. website at www.genmarkdx.com under the investor relations section and will be archived for future reference. To listen to
the conference call, please dial (877) 312-5847 (US/Canada) or (253) 237-1154 (International) and use the conference ID number
89238764 approximately five minutes prior to the start time.
ABOUT GENMARK DIAGNOSTICS
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient
care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMark's proprietary eSensor® detection
technology, GenMark's eSensor XT-8® and ePlex® systems are designed to support a broad range of molecular diagnostic tests with
compact, easy-to-use workstations and self-contained, disposable test cartridges. GenMark’s ePlex: The True Sample-to-Answer
Solution™ is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs,
including respiratory, bloodstream, and gastrointestinal infections. For more information, visit www.genmarkdx.com.
GenMark Diagnostics, Inc.
Hany Massarany
President/Chief Executive Officer
760-448-4325
View source version on businesswire.com: http://www.businesswire.com/news/home/20171019006468/en/